MX2021001888A - Composiciones que comprenden cepas bacterianas. - Google Patents

Composiciones que comprenden cepas bacterianas.

Info

Publication number
MX2021001888A
MX2021001888A MX2021001888A MX2021001888A MX2021001888A MX 2021001888 A MX2021001888 A MX 2021001888A MX 2021001888 A MX2021001888 A MX 2021001888A MX 2021001888 A MX2021001888 A MX 2021001888A MX 2021001888 A MX2021001888 A MX 2021001888A
Authority
MX
Mexico
Prior art keywords
compositions
bacterial strains
stimulating
subject
composition
Prior art date
Application number
MX2021001888A
Other languages
English (en)
Inventor
Amy Beth HOLT
Imke Elisabeth MULDER
Suaad Ahmed
Emma Raftis
Emma Elizabeth Clare Hennessy
Delphine Louise Claudette Laute-Caly
Philip Cowie
Marsilio Adriani
Maria Christofi
Anna Ettorre
Original Assignee
4D Pharma Res Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1817648.7A external-priority patent/GB201817648D0/en
Priority claimed from GBGB1900335.9A external-priority patent/GB201900335D0/en
Priority claimed from GBGB1901203.8A external-priority patent/GB201901203D0/en
Application filed by 4D Pharma Res Limited filed Critical 4D Pharma Res Limited
Publication of MX2021001888A publication Critical patent/MX2021001888A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La invención proporciona una composición que comprende una cepa bacteriana para su uso en la estimulación del sistema inmunológico en un sujeto.
MX2021001888A 2018-08-17 2019-08-19 Composiciones que comprenden cepas bacterianas. MX2021001888A (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP18189521 2018-08-17
GBGB1817648.7A GB201817648D0 (en) 2018-10-29 2018-10-29 Compositions comprising bacterial strains
GBGB1900335.9A GB201900335D0 (en) 2019-01-10 2019-01-10 Compositions comprising bacterial strains
GBGB1901203.8A GB201901203D0 (en) 2019-01-29 2019-01-29 Compositions comprising bacterial strains
PCT/EP2019/072181 WO2020035623A1 (en) 2018-08-17 2019-08-19 Compositions comprising bacterial strains

Publications (1)

Publication Number Publication Date
MX2021001888A true MX2021001888A (es) 2021-07-16

Family

ID=67874412

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021001888A MX2021001888A (es) 2018-08-17 2019-08-19 Composiciones que comprenden cepas bacterianas.

Country Status (14)

Country Link
US (1) US20210330786A1 (es)
EP (1) EP3836945A1 (es)
JP (1) JP2021534089A (es)
KR (1) KR20210046007A (es)
CN (1) CN113423413A (es)
AU (1) AU2019322090A1 (es)
BR (1) BR112021002917A2 (es)
CA (1) CA3108235A1 (es)
IL (1) IL280895A (es)
MA (1) MA53228A (es)
MX (1) MX2021001888A (es)
SG (1) SG11202101580TA (es)
TW (1) TW202023590A (es)
WO (1) WO2020035623A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112195123B (zh) * 2020-10-12 2022-04-29 中科美大(福建)生物科技有限公司 一种植物乳杆菌及其制剂和应用
CN112522248B (zh) * 2020-11-10 2023-10-03 暨南大学 一种包裹型阴沟肠杆菌y16固体菌剂的制备方法及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0127916D0 (en) 2001-11-21 2002-01-16 Rowett Res Inst Method
KR20120038021A (ko) 2006-10-27 2012-04-20 화이자 프로덕츠 인코포레이티드 하이드록시프로필 메틸 셀룰로스 경질 캡슐 및 이의 제조 방법
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
WO2010143940A1 (en) 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
KR101156340B1 (ko) 2009-06-17 2012-06-13 고려대학교 산학협력단 비피도박테리움 브레베 ｌｍｃ５２０ 균주를 이용한 공액리놀렌산의 생산방법
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
US10300137B2 (en) * 2014-04-10 2019-05-28 Riken Compositions and methods for induction of TH17 cells
MA41020A (fr) * 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
LT3206700T (lt) 2015-06-15 2019-08-26 4D Pharma Research Limited Kompozicijos, apimančios bakterijų kamienus
WO2017209156A1 (ja) 2016-05-31 2017-12-07 森永乳業株式会社 脳機能改善剤

Also Published As

Publication number Publication date
US20210330786A1 (en) 2021-10-28
EP3836945A1 (en) 2021-06-23
KR20210046007A (ko) 2021-04-27
WO2020035623A1 (en) 2020-02-20
BR112021002917A2 (pt) 2021-05-11
AU2019322090A1 (en) 2021-04-15
CN113423413A (zh) 2021-09-21
IL280895A (en) 2021-04-29
CA3108235A1 (en) 2020-02-20
JP2021534089A (ja) 2021-12-09
SG11202101580TA (en) 2021-03-30
MA53228A (fr) 2021-11-24
TW202023590A (zh) 2020-07-01

Similar Documents

Publication Publication Date Title
MX2020012061A (es) Composiciones que comprenden cepas bacterianas.
SA517390513B1 (ar) تركيبات تشتمل على سلالات بكتيرية
NZ749872A (en) Compositions comprising bacterial strains
MX2018006239A (es) Composiciones que comprenden cepas bacterianas.
MX2018006398A (es) Composiciones que comprenden cepas bacterianas.
MX2018006399A (es) Composiciones que comprenden cepas bacterianas.
MX2021000710A (es) Composiciones que comprenden cepas bacterianas.
MX2017016529A (es) Composiciones que comprenden cepas bacterianas.
MX2017016564A (es) Composiciones que comprenden cepas bacterianas.
MX2020005772A (es) Composiciones que comprenden cepas bacterianas.
MX2017016560A (es) Composiciones que comprenden cepas bacterianas.
MX2017016525A (es) Composiciones que comprenden cepas bacterianas.
MX2020009736A (es) Composiciones que comprenden cepas bacterianas.
GB201708182D0 (en) Compositions comprising bacterial strains
EP4241851A3 (en) Immunogenic compositions
MX2021001888A (es) Composiciones que comprenden cepas bacterianas.
MX2021006863A (es) Composiciones que comprenden cepas bacterianas de parabacteroides para tratar el cancer.
MX2021004150A (es) Composiciones que comprenden cepas bacterianas.
MX2020001632A (es) Composiciones que comprenden cepas bacterianas.
EA202190554A1 (ru) Композиции, содержащие бактериальные штаммы
EA202092549A1 (ru) Композиции, содержащие бактериальные штаммы
LT3723777T (lt) Kompozicijos, apimančios bakterines padermes
GB201810386D0 (en) Compositions comprising bacterial strains
PL3898938T3 (pl) Bionawożący szczep bakterii
PL3898939T3 (pl) Bionawożący szczep bakterii